Cancer Genomics Expert To Present Annual Block Lecture

October 23, 2012
Cancer Genomics Expert To Present Annual Block Lecture Levi Garraway

COLUMBUS, Ohio – Dr. Levi Garraway, an associate professor of medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School, and a senior associate member of the Broad Institute, has been selected to receive the 19th annual Herbert and Maxine Block Memorial Lectureship Award for Achievement in Cancer. He will visit The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) on Wednesday (10/24) to deliver the Block Lecture.

The award, established by the Block family of Columbus, honors the memory of their parents, Maxine and Herbert J. Block, who both died of cancer. It is given annually to a renowned cancer researcher who is invited to OSUCCC-James to accept the award and deliver the annual Block Lecture.

Garraway will present "An Integrative Framework for 'Precision' Cancer Medicine," at 8 a.m. Wednesday (10/24) in 518 James.

An internationally renowned oncologist and researcher, Garraway leads an investigative team in cancer genomics at Dana-Farber and the Broad Institute, and he is co-leader of the Cancer Genetics Program at the Dana-Farber/Harvard Cancer Center. He has made significant research contributions in cancer genomics, drug resistance and genomics-driven (or "personalized") cancer medicine. He published the first gene-sequencing studies of aggressive prostate cancer and has led other major gene-sequencing initiatives in prostate cancer, melanoma, and head and neck cancers.

Garraway's scholarly work has consistently been published in the world's top scientific journals. In recognition of his contributions, he has been the recipient of several awards and honors including induction into the American Society for Clinical Investigation in 2009.

A monetary award of $25,000 is associated with the Block Memorial Lectureship, making it one of the largest prizes awarded by an academic institution in the field of cancer. The Block Memorial Lectureship is funded by proceeds of the annual Herbert J Block Memorial Tournament, a golf outing established in 1982 by the Block family of Columbus to honor their father. The event has raised more than $4.5 million for cancer research at OSUCCC-James. The lecture is free, but seating is limited. To make a reservation, e-mail Nancy Jones at

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.

# # #

Contact: Eileen Scahill, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, or

Contact Media Staff

Amanda Harper

Director of Media Relations

614-685-5420 (direct)

614-293-3737 (main)

Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.


If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Ohio State, ORIEN Could Play Role in Vice President's Cancer Moonshot Initiative

ORIEN, a network formed by Ohio State and Moffitt Cancer Center, could play an important role in the White House Cancer Moonshot initiative by facilitating the sharing of important data.

Ohio State: An Exceptional Comprehensive Cancer Center Helping Cancer Patients

Director of the OSUCCC Dr. Michael Caligiuri discusses the importance of being an NCI-designated comprehensive cancer center, where research flourishes and the best scientists and physicians want to work.

A Fireside Chat with The James CEO Dr. Michael Caligiuri

Dr. Caligiuri hosts a chat where he talked about the “exceptional” rating The James recently received from the NCI, advances in immunology & how ORIEN could play a role in the cancer “moonshot” program.